Done sou Salè H1B

Akèy › Kat vèt › Glenmark Pharmaceuticals, Inc. USA

Glenmark Pharmaceuticals, Inc. USA: sponso kat vèt (PERM)

Glenmark Pharmaceuticals, Inc. USA te depoze 5 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 3. Mwayèn salè yo ofri $152,630; mwayèn tan soti nan depozisyon jiska sètifikasyon: 476 jou.

Aplikasyon PERM5
Sètifye3
Salè medyan ofri$152,630
Mwayèn jou pou sètifikasyon476
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)112
Nan biznis depi2002
Adrès anplwayèMahwah, NJ

Salè H-1B nan Glenmark Pharmaceuticals, Inc. USA →

Tit travay

Tit travayAplikasyon PERMSalè medyan
Sr. Validation Specialist, Pharmaceuticals3$108,202
Manager, Manufacturing Science and Technology (MSAT)1$152,630
QC Stability, Senior Manager1$152,630

Kote travay

Okipasyon

Dènye desizyon

Tit travaySalè bazKoteSoumètDesideEstatiJou
QC Stability, Senior Manager$152,630Monroe, NCFeb 13, 2025May 8, 2026Sètifye449
Manager, Manufacturing Science and Technology (MSAT)$152,630Monroe, NCOct 31, 2024Feb 19, 2026Sètifye476
Sr. Validation Specialist, Pharmaceuticals$108,202Monroe, NCSep 24, 2024Feb 11, 2026Sètifye505
Sr. Validation Specialist, Pharmaceuticals$108,202Monroe, NCSep 24, 2024Jul 9, 2025Retire—
Sr. Validation Specialist, Pharmaceuticals$108,202Monroe, NCSep 24, 2024Sep 24, 2024Retire—

Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).